About Relievant Medsystems
Relievant Medsystems is a Healthcare company based in Redwood City (United States) founded in 2004, and was acquired by Boston Scientific in September 2023. Developer of medical devices for patients suffering from chronic vertebrogenic low back pain. Relievant Medsystems has raised $273.05 million across 10 funding rounds from investors including Boston Scientific, Canaan and Ally Bridge Group. Relievant Medsystems offers products and services including Intracept Procedure and Clinical Trials Services. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is Relievant Medsystems, Inc. Its competitors include Nevro, ATEC Spine and Vertos Medical; 2 of its 3 listed competitors have raised funding.
Company details
Relievant Medsystems was founded in 2004 and is based in Redwood City, United States. Operations focus on the medical devices sector, where solutions are created for patients with chronic vertebrogenic low back pain. The Intracept System is utilized to deliver targeted energy into the spine, thereby blocking pain signal transmission from the basivertebral nerve. Development and distribution occur within the healthcare technology field.
- Headquarters Redwood City, United States
- Stage Acquired
- SectorsHealthcare
- Website relievant.com
- Social LinkedIn X
- Acquired by Boston Scientific (Sep 2023)
- Legal Name Relievant Medsystems, Inc.
- Total Equity Funding$273.05M (USD)
in 10 rounds
- Latest Funding Round$50M (USD), Series G
Mar 2023
- InvestorsBoston Scientific
& 12 more
- Acquired byBoston Scientific
(Sep 2023)
Products & Services of Relievant Medsystems
Relievant Medsystems offers a comprehensive portfolio of products and services, including Intracept Procedure and Clinical Trials Services.
Minimally invasive treatment for vertebrogenic low back pain relief.
Provides evidence-based analysis for pain management solutions.
Funding Insights of Relievant Medsystems
Relievant Medsystems has successfully raised a total of $273.05M across 10 strategic funding rounds. The most recent funding activity was a Series G round of $50 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $273.05M
- Total Rounds 10
- Last Round Series G β $50M
- First Round $5.05M
(Jul 2006)
- Investors Count 12
All 10 funding rounds of Relievant Medsystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | $50M | Series G | β | Ally Bridge Group | |
| Oct 2020 | $70M | Series F | β | Vensana Capital, Lightstone Ventures | |
| Jun 2018 | $58M | Series E | β | Endeavour Vision | |
| Aug 2016 | $36M | Series E | β | New Enterprise Associates | |
| Dec 2015 | $1.5M | Debt – Conventional | β | β | β |
| Feb 2015 | $3M | Debt – Conventional | β | β | β |
| Mar 2012 | $30M | Series D | β | β | |
| Jul 2009 | $20M | Series C | β | β | |
| Apr 2008 | $4M | Series B | β | β | β |
| Jul 2006 | $5.05M | Series B | β | β |
13 investors in total: 13 institutional.
Investors in Relievant Medsystems
Relievant Medsystems has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Canaan and Ally Bridge Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and hedge fund investments in healthcare are managed. | ally-bridge.com | Hong Kong, China | ||
Endeavour Vision is focused on transformative healthcare technology investments. | endeavourvision.com | Geneva, Switzerland | ||
Investments in medical technology are made by Vensana Capital. | vensanacap.com | Minneapolis, United States | ||
Venture capital fund and fund of funds focused on the life science sector | lightstonevc.com | Menlo Park, United States | ||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Canaan is recognized as an early-stage venture capital firm. | 1987 | canaan.com | San Francisco, United States | |
Venture capital and private equity investment firm | morgenthaler.com | Portola Valley, United States | ||
Seed-stage venture capital focused on enterprise AI, intelligent software, and cloud technologies. | emergent.vc | |||
Funding and expertise are provided for medical device development. | 2017 | emvllp.com | San Jose, United States | |
Early stage VC firm investing in the US | onset.com | Menlo Park, United States |
Investor details for Relievant Medsystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Relievant Medsystems
43 people are tracked at Relievant Medsystems (10 in leadership, 7 in board & advisors, 26 in team).
| Name | Role | Group |
|---|---|---|
Chris Geyen | CFO | Leadership |
Bryan Holmes | VP, Marketing & Strategy | Leadership |
Kevin Lau | Senior Director Supply Chain | Leadership |
Matt Kraemer | Sr. Director Of R&d, Operations And Program Management | Leadership |
Karen Bobbitt | Director, Market Access And Reimbursement | Leadership |
Dale Zunke | Sr. Director Of Professional Education | Leadership |
Rick F. | Director Supply Chain | Leadership |
Alain Adam | Director, Strategic Initiatives | Leadership |
Michael Marks M.D. | Senior Medical Director | Leadership |
Brian Suter | Director Of Commercial Acceleration | Leadership |
Art Taylor | Director | Board & advisors |
Jason Lettman | Director | Board & advisors |
David R. Amerson | Director | Board & advisors |
Richard Mott | Chairman | Board & advisors |
Justin Klein | Director | Board & advisors |
Brent Ahrens | Director | Board & advisors |
Tiffany Le | Director | Board & advisors |
Haley Eck | Clinical Specialist Trainer - Central | Team |
Blake Torok | Clinical Specialist | Team |
Yvonne Johnson | Clinical Specialist Trainer - West | Team |
23 more people are available in the full profile.
Complete people profiles for Relievant Medsystems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Relievant Medsystems
4 dated milestones of Relievant Medsystems across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Relievant Medsystems is founded.
- Funding First funding round of $5.1M.
- Funding Latest funding round, Series G, of $50.0M.
- Exit Acquired by Boston Scientific.
Competitors of Relievant Medsystems
Relievant Medsystems has 3 listed competitors in our database, 2 of them funded. They include Nevro, ATEC Spine and Vertos Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nevro.com | 2006 | Menlo Park, United States | $154.1M | 1,215 | Provider of high-frequency spinal cord stimulation implants | |
| atecspine.com | 1990 | San Diego, United States | 839 | Treatment solutions for spine disorders are developed. | ||
| vertosmed.com | 2005 | Aliso Viejo, United States | $177.75M | 140 | Minimally invasive treatments for lumbar spinal stenosis are developed. |
Detailed competitors of Relievant Medsystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Relievant Medsystems
Websites that share an audience with Relievant Medsystems (relievant.com).
Websites whose visitors overlap most with Relievant Medsystems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
thepaincenter.com | thepaincenter.com | 100% | #1,178,963 | β | |
parkridgehealth.com | parkridgehealth.com | 94% | #556,529 | β | |
news.bostonscientific.com | news.bostonscientific.com | 88% | #959,611 | β | |
axisspinecenter.com | axisspinecenter.com | 71% | #3,549,048 | β | |
| reliefband.com | 71% | 21.5K | #1,220,750 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 8 similar websites and full traffic analytics for Relievant Medsystems
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as Relievant Medsystems (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Relievant Medsystems
Complete news archive for Relievant Medsystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Relievant Medsystems
Relievant Medsystems was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Relievant Medsystems is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Relievant Medsystems is a funded company, having raised a total of $273.05M across 10 funding rounds to date. The company's 1st funding round was a Series B of $5.05M, raised on Jul 2006.
Relievant Medsystems was founded in 2004 and is based in Redwood City, United States. Operations focus on the medical devices sector, where solutions are created for patients with chronic vertebrogenic low back pain. The Intracept System is utilized to deliver targeted energy into the spine, thereby blocking pain signal transmission from the basivertebral nerve. Development and distribution occur within the healthcare technology field.
Relievant Medsystems's top competitors include Nevro, ATEC Spine and Vertos Medical.
Relievant Medsystems offers Intracept Procedure and Clinical Trials Services.
Relievant Medsystems has 13 investors. Key investors include Boston Scientific, Canaan, Ally Bridge Group, Endeavour Vision, and Vensana Capital.
Relievant Medsystems operates through Relievant Medsystems, Inc..
Yes. Relievant Medsystems was acquired by Boston Scientific in September 2023.

